Related Experiment Video
Updated: Jan 2, 2026

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by GalliumIII and H3 5,10,15-trispentafluorophenylcorroles
Published on: March 18, 2015
Coronarin D Induces Apoptotic Cell Death and Cell Cycle Arrest in Human Glioblastoma Cell Line
Yollanda E M Franco1,2, Marcia Y Okubo3,4, Adriana D Torre3
1Research Laboratory in Molecular Pharmacology of Bioactive Compounds. São Francisco University, Bragança Paulista 12916-900, SP, Brazil.
Abstract:
Glioblastoma (GBM) is the most frequent and highest-grade brain tumor in adults. The prognosis is still poor despite the use of combined therapy involving maximal surgical resection, radiotherapy, and chemotherapy. The development of more efficient drugs without noticeable side effects is urgent. Coronarin D is a diterpene obtained from the rhizome extract of Hedychium coronarium, classified as a labdane with several biological activities, principally anticancer potential. The aim of the present study was to determine the anti-cancer properties of Coronarin D in the glioblastoma cell line and further elucidate the underlying molecular mechanisms. Coronarin D potently suppressed cell viability in glioblastoma U-251 cell line, and also induced G1 arrest by reducing p21 protein and histone H2AX phosphorylation, leading to DNA damage and apoptosis. Further studies showed that Coronarin D increased the production of reactive oxygen species, lead to mitochondrial membrane potential depolarization, and subsequently activated caspases and ERK phosphorylation, major mechanisms involved in apoptosis. To our knowledge, this is the first analysis referring to this compound on the glioma cell line. These findings highlight the antiproliferative activity of Coronarin D against glioblastoma cell line U-251 and provide a basis for further investigation on its antineoplastic activity on brain cancer.
Insights
Coronarin D effectively suppressed glioblastoma cell growth by inducing DNA damage and apoptosis. This diterpene shows promise as a novel anticancer agent for brain tumors.
Area of Science:
- Natural Products Chemistry
- Molecular Biology
- Oncology
Background:
- Glioblastoma (GBM) is an aggressive brain tumor with poor prognosis despite standard treatments.
- Novel therapeutic agents with improved efficacy and reduced side effects are urgently needed for GBM treatment.
Purpose of the Study:
- To investigate the anticancer properties of Coronarin D in a human glioblastoma cell line (U-251).
- To elucidate the molecular mechanisms underlying Coronarin D's anti-glioblastoma effects.
Main Methods:
- Cell viability assays were performed on U-251 glioblastoma cells treated with Coronarin D.
- Cell cycle progression, DNA damage markers (p21, H2AX phosphorylation), reactive oxygen species (ROS) production, and mitochondrial membrane potential were analyzed.
- Apoptosis-related proteins (caspases) and signaling pathways (ERK phosphorylation) were assessed.
Main Results:
- Coronarin D significantly inhibited U-251 cell viability.
- The compound induced G1 cell cycle arrest, DNA damage, and apoptosis.
- Coronarin D increased ROS production, depolarized mitochondrial membrane potential, and activated caspases and ERK signaling.
Conclusions:
- Coronarin D exhibits potent antiproliferative and pro-apoptotic effects against glioblastoma U-251 cells.
- The mechanisms involve cell cycle arrest, DNA damage induction, ROS generation, and caspase activation.
- Coronarin D represents a potential therapeutic candidate for brain cancer treatment, warranting further investigation.
More Related Videos
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
08:21Cell Cycle-specific Measurement of γH2AX and Apoptosis After Genotoxic Stress by Flow Cytometry
Published on: September 1, 2019
Related Concept Videos
Inhibition of Cdk Activity
Apoptosis
The Intrinsic Apoptotic Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...